Question Everything. See who's reporting it.

Nucelion and Pandorum Partner on Ophthalmology Projects

Source: Telangana Today

The story in brief

Hyderabad-based Nucelion Therapeutics and Bengaluru’s Pandorum Technologies have partnered to advance two PRIP-backed ophthalmology projects targeting advanced keratopathy and wet AMD. Pandorum’s designer-exosome platform and Nucelion’s GMP expertise will combine for a planned outlay of Rs 16.97 crore, with Rs 8 crore under PRIP. The projects aim to support clinical studies in India and globally.

2 outletsSee what the other 1 outlet said

NEWXFree on Android and iPhone. Open in NEWX